Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): a comprehensive analysis by tumour site.
about
HPV Positive Head and Neck Cancers: Molecular Pathogenesis and Evolving Treatment StrategiesAdvanced oropharyngeal squamous cell carcinoma: Pathogenesis, treatment, and novel therapeutic approachesAnimal models to study the mutational landscape for oral cavity and oropharyngeal cancersThe Role of Lymphocytes in Radiotherapy-Induced Adverse Late Effects in the LungAn update on larynx cancerManagement of locally advanced HPV-related oropharyngeal squamous cell carcinoma: where are we?Treatment-related outcome of oropharyngeal cancer patients differentiated by HPV dictated risk profile: a tertiary cancer centre series analysis.Treatment trends and survival effects of chemotherapy for hypopharyngeal cancer: Analysis of the National Cancer Data Base.A comparison of overall survival for patients with T4 larynx cancer treated with surgical versus organ-preservation approaches: A National Cancer Data Base analysis.Concurrent hyperfractionated accelerated radiotherapy with 5-FU and once weekly cisplatin in locally advanced head and neck cancer. The 10-year results of a prospective phase II trial.A meta-analysis comparing cisplatin-based to carboplatin-based chemotherapy in moderate to advanced squamous cell carcinoma of head and neck (SCCHN).Advances in the management of squamous cell carcinoma of the head and neck.Intensity-modulated proton beam therapy (IMPT) versus intensity-modulated photon therapy (IMRT) for patients with oropharynx cancer - A case matched analysis.Efficacy and toxicity of docetaxel combination chemotherapy for advanced squamous cell cancer of the head and neck.The role of transoral robotic surgery in the management of oropharyngeal cancer: a review of the literature.Stereotactic body radiotherapy as primary therapy for head and neck cancer in the elderly or patients with poor performance.Is open surgery for head and neck cancers truly declining?Nuclear expression of p65 (RelA) in patients receiving post-operative radiotherapy for locally advanced squamous cell carcinoma of the head and neck.The Rapalogue, CCI-779, improves salivary gland function following radiation.Survival and selected outcomes of older adults with locally advanced head/neck cancer treated with chemoradiation therapy.An observational study of social control, mood, and self-efficacy in couples during treatment for head and neck cancer.Feasibility and Safety of Overtubes for PEG-Tube Placement in Patients with Head and Neck Cancer.Clinical outcomes associated with evolving treatment modalities and radiation techniques for base-of-tongue carcinoma: thirty years of institutional experience.Functional swallowing outcomes following treatment for oropharyngeal carcinoma: a systematic review of the evidence comparing trans-oral surgery versus non-surgical management.Treatment of T3 laryngeal cancer in the Netherlands: a national survey.Regional recurrence of oropharyngeal cancer after definitive radiotherapy: a case control study.Oropharyngeal squamous cell carcinoma in the veteran population: Association with traditional carcinogen exposure and poor clinical outcomes.Survival, recurrence and toxicity of HNSCC in comparison of a radiotherapy combination with cisplatin versus cetuximab: a meta-analysisConcurrent radiochemotherapy in locally-regionally advanced oropharyngeal squamous cell carcinoma: analysis of treatment results and prognostic factors.Subcellular localisation of pMEK has a different prognosis in locally advanced head and neck cancer treated with concomitant radiochemotherapy.Minimally invasive surgery versus radiotherapy/chemoradiotherapy for small-volume primary oropharyngeal carcinoma.Perioperative changes in osteopontin and TGFβ1 plasma levels and their prognostic impact for radiotherapy in head and neck cancer.Intravoxel Incoherent Motion Diffusion-weighted Magnetic Resonance Imaging for Monitoring the Early Response to ZD6474 from Nasopharyngeal Carcinoma in Nude Mouse.EGFR Monoclonal Antibodies in the Treatment of Squamous Cell Carcinoma of the Head and Neck: A View beyond Cetuximab.Head and Neck Squamous Cell Carcinoma in Iran: Clinico-Pathological and Treatment-Related Factors Influencing Survival.Preliminary study of transoral robotic surgery for pharyngeal cancer in JapanSystemic therapy in head and neck cancer: changing paradigm.Outcomes of patients with loco-regionally recurrent or new primary squamous cell carcinomas of the head and neck treated with curative intent reirradiation at Mayo ClinicRadiotherapy in head and neck cancer management: United Kingdom National Multidisciplinary Guidelines.Hypopharyngeal cancer: United Kingdom National Multidisciplinary Guidelines.
P2860
Q26752584-723B6F40-AAC1-488A-BEA3-6FCFA5FAF10FQ26767046-E3F58ED3-168C-4D2F-BBF0-858313E22985Q27026169-0A1E04EB-0A66-47FD-BCAA-008243959A5FQ28070412-58440960-954E-453B-B298-C905F33E751AQ28079132-FC19EBDB-437F-45BC-9649-F27EEC142931Q30252081-A4F6CE3B-49C8-4367-9A54-3D2AC3B8C710Q30650708-C62F0604-B7E3-4437-B924-B500AAD92A5FQ31063952-8A147BC2-38EE-405D-AA42-F4BFB424F3D7Q31136094-C89F79F3-DFA4-435A-980B-DECD5938FB0BQ33412010-D64463B4-85B3-41EF-94F2-0E6E20890D9AQ33429085-E14771D8-A34B-472D-8F2E-A43665EE757DQ33720431-922CE242-69D5-45E4-9997-E60DDB0FA67FQ33809126-DF6D2555-0AFB-4EFD-8B89-C641F26068BDQ33858049-FD0EB8BD-13AA-4EAF-BEF9-91B5183BE633Q34273992-AC44E47B-4E48-4D12-8005-900354213384Q34306100-99F7938D-E92B-498E-9F8F-8FA9F9B3F90FQ34530861-2E132979-8294-4A76-8D2C-EE05FF06ECE8Q35156335-C79DEBA3-1E73-4D94-B2A0-CB7A848FA9C9Q35463371-36D6C9CE-34F4-4BC9-92F4-3E3426063A00Q35551059-0C2B55AC-912B-439F-94B9-6CF61F65332AQ35553895-973ACB9F-7EBB-41F8-A0DF-4B3847EE236EQ35568165-F7591A41-9DF0-47DB-87AE-9F93FAEC3B13Q35602115-F21A483B-B473-4376-8B57-DAE9FB549FAFQ35751664-5B4752C9-7D10-49BC-946C-CAC7B7455FDFQ35782292-7C8764DA-92AA-42A7-BF64-162CBBE99B84Q35814887-932D531A-2F13-4413-8BDD-2B5B17A5FC2EQ35832792-5610140F-CA98-4630-9FE6-3DC5B4DD05D5Q36114633-62632EED-191C-4F55-8CE1-8E01CFEE7DA8Q36116471-1D1AA978-0322-49C5-8F28-67824505277CQ36177680-3AC43A6A-2114-4D8B-8322-69360CF60446Q36220456-27818881-DDF0-4987-82ED-8B0F05C2F5BCQ36238876-2DE4EA96-8BD0-469A-B2F6-2E1D5DFFCAD7Q36287670-88D91957-B966-4F80-891B-63F328FE4B6DQ36302347-9AF66FD4-6BFE-4E9E-AC49-947EB01AAE43Q36340192-D4B3921B-C532-42BA-8F26-6863D707FFB5Q36615068-EEEF8D0A-1036-4246-A4E1-FEEF8001376BQ36627358-AFF0363D-535D-45D3-9D18-911A74A08D70Q36783381-18851351-A155-4842-B308-7CB485E4EEB9Q36919560-6234FE5D-6247-4DBD-9645-46E4F1214188Q36919598-740299DD-E410-4B69-93FF-335C8194BB77
P2860
Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): a comprehensive analysis by tumour site.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Meta-analysis of chemotherapy ...... nsive analysis by tumour site.
@ast
Meta-analysis of chemotherapy ...... nsive analysis by tumour site.
@en
Meta-analysis of chemotherapy in head and neck cancer
@nl
type
label
Meta-analysis of chemotherapy ...... nsive analysis by tumour site.
@ast
Meta-analysis of chemotherapy ...... nsive analysis by tumour site.
@en
Meta-analysis of chemotherapy in head and neck cancer
@nl
prefLabel
Meta-analysis of chemotherapy ...... nsive analysis by tumour site.
@ast
Meta-analysis of chemotherapy ...... nsive analysis by tumour site.
@en
Meta-analysis of chemotherapy in head and neck cancer
@nl
P2093
P1476
Meta-analysis of chemotherapy ...... ensive analysis by tumour site
@en
P2093
Abderrahmane Bourredjem
Bertrand Baujat
Charlotte Baey
Jean Bourhis
MACH-CH Collaborative group
Pierre Blanchard
Victoria Holostenco
P356
10.1016/J.RADONC.2011.05.036
P577
2011-06-16T00:00:00Z